For women with a specific type of breast cancer known as HER2-positive (HER2+), any residual (leftover) disease after primary treatment with surgery, chemotherapy, and/or targeted drugs means the risk ...

What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

The risk of isolated locoregional recurrence after initial treatment was 5.6% among young women diagnosed with breast cancer. This was lower than a previously reported 10-year rate of 8% among all ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Exercising regularly in the three years after treatment for a common cancer could significantly improve survival rates, an international study has revealed. In the research, a total of 889 colon ...

June 10, 2010 — Surgery to remove solid tumors can trigger metastatic spread. A groundbreaking analysis by Patrice Forget, MD, and colleagues from the Université catholique de Louvain, in ...

Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...